1.
Brusamolino E, Passamonti F, Pagnucco G, Castagnola C, Lazzarino M, Bernasconi C. Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphoma. Haematologica 1998; 83(4):323-328.